BCRX Stock Summary and Trading Ideas (Biocryst Pharmaceuticals | NASDAQ:BCRX)

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

What symbol and exchange does Biocryst Pharmaceuticals shares trade?

Biocryst Pharmaceuticals trades on the NASDAQ stock market under the symbol BCRX.

What is Biocryst Pharmaceuticals stock price doing today?

As of April 20, 2026, BCRX stock price declined to $9.12 with 1,210,903 million shares trading.

What is Biocryst Pharmaceuticals's Beta?

BCRX has a beta of 0.13, meaning it tends to be less sensitive to market movements. BCRX has a correlation of 0.00 to the broad based SPY ETF.

How much is Biocryst Pharmaceuticals worth?

BCRX has a market cap of $2.26 billion. This is considered a Mid Cap stock.

How much money does Biocryst Pharmaceuticals make?

Last quarter Biocryst Pharmaceuticals reported $163 million in Revenue and $.06 earnings per share. This beat revenue expectation by $13 million and missed earnings estimates by -$.02.

What is the highest and lowest price Biocryst Pharmaceuticals traded in the last 3 year period?

In the last 3 years, BCRX traded as high as $11.31 and as low as $4.03.

What are the top ETFs holding Biocryst Pharmaceuticals?

The top ETF exchange traded funds that BCRX belongs to (by Net Assets): VTI, XBI, IWM, VB, VXF.

Is Biocryst Pharmaceuticals (BCRX) a good investment?

BCRX has underperformed the market in the last year with a price return of +23.2% while the SPY ETF gained +35.9%. However, in the short term, BCRX had mixed performance relative to the market. It has outperformed in the last 3 months, returning +36.9% vs +2.7% return in SPY. But in the last 2 weeks, BCRX shares have been beat by the market, returning +1.1% compared to an SPY return of +8.0%.

What are the support and resistance levels for Biocryst Pharmaceuticals (BCRX)?

BCRX support price is $9.20 and resistance is $9.80 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BCRX shares will trade within this expected range on the day.